WO2009011426A1 - γ-セクレターゼの新規基質c-Metを利用したスクリーニング方法 - Google Patents
γ-セクレターゼの新規基質c-Metを利用したスクリーニング方法 Download PDFInfo
- Publication number
- WO2009011426A1 WO2009011426A1 PCT/JP2008/063037 JP2008063037W WO2009011426A1 WO 2009011426 A1 WO2009011426 A1 WO 2009011426A1 JP 2008063037 W JP2008063037 W JP 2008063037W WO 2009011426 A1 WO2009011426 A1 WO 2009011426A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- met
- secretase
- screening method
- method utilizing
- novel substrate
- Prior art date
Links
- 102000002659 Amyloid Precursor Protein Secretases Human genes 0.000 title abstract 5
- 108010043324 Amyloid Precursor Protein Secretases Proteins 0.000 title abstract 5
- 238000000034 method Methods 0.000 title abstract 2
- 238000012216 screening Methods 0.000 title abstract 2
- 239000000758 substrate Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 7
- 238000003776 cleavage reaction Methods 0.000 abstract 2
- 230000007017 scission Effects 0.000 abstract 2
- 239000012634 fragment Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
- C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
- G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/02—Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Endocrinology (AREA)
- Medicinal Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Cell Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Food Science & Technology (AREA)
- Genetics & Genomics (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Enzymes And Modification Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
本発明は、γ-セクレターゼによるc-Metのプロセシングに影響を与える化合物をスクリーニングする方法であって、以下のステップ: (i)候補化合物の存在下および非存在下で、γ-セクレターゼまたはその生物学的に活性な断片を含む第1の生物学的組成物と、c-Metを含む第2の生物学的組成物とを接触させ; (ii)当該候補化合物の存在下および非存在下における当該c-Metの開裂をそれぞれ測定し; (iii)γ-セクレターゼによる当該c-Metの開裂に影響を与える候補化合物を選択し;そして (iv)前記(iii)で得られた候補化合物を、γ-セクレターゼによるc-Metのプロセシングに影響を与える化合物であると同定する、 ことを含む、上記方法。
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2009523688A JPWO2009011426A1 (ja) | 2007-07-19 | 2008-07-18 | γ−セクレターゼの新規基質c−Metを利用したスクリーニング方法 |
EP08791346A EP2177623A4 (en) | 2007-07-19 | 2008-07-18 | SCREENING METHOD USING C-MET, A NEW SUBSTRATE FOR GAMMA SECRETASE |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US95062107P | 2007-07-19 | 2007-07-19 | |
US60/950,621 | 2007-07-19 | ||
US95149307P | 2007-07-24 | 2007-07-24 | |
US60/951,493 | 2007-07-24 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2009011426A1 true WO2009011426A1 (ja) | 2009-01-22 |
Family
ID=40259752
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2008/063037 WO2009011426A1 (ja) | 2007-07-19 | 2008-07-18 | γ-セクレターゼの新規基質c-Metを利用したスクリーニング方法 |
Country Status (4)
Country | Link |
---|---|
US (1) | US20090191580A1 (ja) |
EP (1) | EP2177623A4 (ja) |
JP (1) | JPWO2009011426A1 (ja) |
WO (1) | WO2009011426A1 (ja) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008150010A1 (ja) * | 2007-06-08 | 2008-12-11 | Eisai R & D Management Co., Ltd. | γ-セクレターゼの新規基質EphA4を利用したスクリーニング方法 |
EP2192181A4 (en) * | 2007-08-01 | 2010-12-08 | Eisai R&D Man Co Ltd | SCREENING METHOD USING THE NEW C-RET SUBSTRATE FOR GAMMA-SECRETASE |
JP5580598B2 (ja) * | 2007-11-15 | 2014-08-27 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | γ−セクレターゼの新規基質EphA7を利用したスクリーニング方法 |
WO2009069808A1 (ja) * | 2007-11-30 | 2009-06-04 | Eisai R & D Management Co., Ltd. | 新規活性を有するEphA4ポリペプチドおよびその用途 |
WO2012059562A1 (en) | 2010-11-03 | 2012-05-10 | Argen-X-Bv | C-met antibody combinations |
US8865426B2 (en) | 2010-12-17 | 2014-10-21 | Eisai R&D Management Co., Ltd. | Screening method using gelatinase-mediated EphA4 cleavage reaction as an indicator |
EP2703814B1 (en) | 2011-04-25 | 2017-11-01 | Eisai R&D Management Co., Ltd. | Method for detecting neurological disease associated with cognitive dysfunction by measuring epha4 extracellular domain |
MA56466A (fr) | 2019-07-01 | 2022-05-11 | Eisai R&D Man Co Ltd | Anticorps anti-epha4 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020068361A1 (en) * | 1997-04-08 | 2002-06-06 | Douglas Clary | Methods of evaluating specific cellular functions of receptor protein tyrosine kinases in a ligand independent manner |
US20060241074A1 (en) * | 2001-08-14 | 2006-10-26 | The General Hospital Corporation | Methods for treatment of pain |
US20070026409A1 (en) * | 2001-08-14 | 2007-02-01 | The General Hospital Corporation | Nucleic acid and amino acid sequences involved in pain |
EP1478772A2 (en) * | 2001-08-14 | 2004-11-24 | The General Hospital Corporation | Nucleic acid and amino acid sequences involved in pain |
JP2004000060A (ja) * | 2002-05-31 | 2004-01-08 | Otsuka Pharmaceut Co Ltd | アミロイドβ産生に影響を与える化合物のスクリーニング方法 |
EP1662259A1 (en) * | 2004-11-25 | 2006-05-31 | Cellzome Ag | Use of Eph receptor inhibitors for the treatment of neurodegenerative diseases |
EP1947193A1 (en) * | 2007-01-17 | 2008-07-23 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Screening method for anti-diabetic compounds |
WO2008150010A1 (ja) * | 2007-06-08 | 2008-12-11 | Eisai R & D Management Co., Ltd. | γ-セクレターゼの新規基質EphA4を利用したスクリーニング方法 |
WO2009012237A1 (en) * | 2007-07-13 | 2009-01-22 | Elan Pharmaceuticals, Inc. | Compositions and methods for identifying substrate specificity of inhibitors of gamma secretase |
EP2192181A4 (en) * | 2007-08-01 | 2010-12-08 | Eisai R&D Man Co Ltd | SCREENING METHOD USING THE NEW C-RET SUBSTRATE FOR GAMMA-SECRETASE |
US20090163594A1 (en) * | 2007-10-31 | 2009-06-25 | Elan Pharmaceuticals, Inc. | Triple Assay System for Identifying Substrate Selectivity of Gamma Secretase Inhibitors |
JP5580598B2 (ja) * | 2007-11-15 | 2014-08-27 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | γ−セクレターゼの新規基質EphA7を利用したスクリーニング方法 |
WO2009069808A1 (ja) * | 2007-11-30 | 2009-06-04 | Eisai R & D Management Co., Ltd. | 新規活性を有するEphA4ポリペプチドおよびその用途 |
US20100113415A1 (en) * | 2008-05-29 | 2010-05-06 | Rajapakse Hemaka A | Epha4 rtk inhibitors for treatment of neurological and neurodegenerative disorders and cancer |
-
2008
- 2008-07-18 US US12/175,595 patent/US20090191580A1/en not_active Abandoned
- 2008-07-18 JP JP2009523688A patent/JPWO2009011426A1/ja not_active Withdrawn
- 2008-07-18 WO PCT/JP2008/063037 patent/WO2009011426A1/ja active Application Filing
- 2008-07-18 EP EP08791346A patent/EP2177623A4/en not_active Withdrawn
Non-Patent Citations (10)
Title |
---|
AKIMOTO M, BABA A, IKEDA-MATSUO Y, YAMADA MK, ITAMURA R, NISHIYAMA N, IKEGAYA Y, MATSUKI N.: "Hepatocyte growth factor as an enhancer of nmda currents and synaptic plasticity in the hippocampus", NEUROSCIENCE, vol. 128, no. 1, 2004, pages 155 - 62 |
GEORGAKOPOULOS A. ET AL.: "Metalloproteinase/Presenilin1 processing of ephrinB regulates EphB-induced Src phosphorylation and signaling", EMBO J., vol. 25, March 2006 (2006-03-01), pages 1242 - 1252, XP008129422 * |
KOPAN R. ET AL.: "Gamma-secretase: proteasome of the membrane?", NAT. REV. MOL. CELL BIOL., vol. 5, June 2004 (2004-06-01), pages 499 - 504, XP008061885 * |
LANDMAN ET AL., CYTOKINE & GROWTH FACTOR REVIEW, vol. 15, 2004, pages 337 - 351 |
NATH D. ET AL.: "Shedding of c-Met is regulated by crosstalk between a G-protein coupled receptor and the EGF receptor and is mediated by a TIMP-3 sensitive metalloproteinase", J. CELL SCI., vol. 114, March 2001 (2001-03-01), pages 1213 - 1220, XP008129432 * |
POZNER-MOULIS ET AL., CANCER RESEARCH, vol. 66, 2006, pages 7976 - 7982 |
SAURA CA, CHOI SY, BEGLOPOULOS V, MALKANI S, ZHANG D, SHANKARANARAYANA RAO BS, CHATTAGI S, KELLEHER RJ 3RD, KANDEL ER, DUFF K: "Loss of presenilin function causes impairments of memory and synaptic plasticity followed by age-dependent neurodegeneration", NEURON, vol. 42, no. 1, 8 April 2004 (2004-04-08), pages 23 - 36 |
See also references of EP2177623A4 |
TYNDALL SJ, WALIKONIS RS.: "The receptor tyrosine kinase Met and its ligand hepatocyte growth factor are clustered at excitatory synapses and can enhance clustering of synaptic proteins", CELL CYCLE, vol. 5, no. 14, 17 July 2006 (2006-07-17), pages 1560 - 8 |
VIDAL G.A. ET AL.: "Presenilin-dependent gamma-secretase processing regulates multiple ERBB4/HER4 activities", J. BIOL. CHEM., vol. 280, no. 20, May 2005 (2005-05-01), pages 19777 - 19783, XP008129417 * |
Also Published As
Publication number | Publication date |
---|---|
EP2177623A4 (en) | 2010-12-29 |
EP2177623A1 (en) | 2010-04-21 |
JPWO2009011426A1 (ja) | 2010-09-24 |
US20090191580A1 (en) | 2009-07-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2009011426A1 (ja) | γ-セクレターゼの新規基質c-Metを利用したスクリーニング方法 | |
WO2008150010A1 (ja) | γ-セクレターゼの新規基質EphA4を利用したスクリーニング方法 | |
EP2402438A3 (en) | Protease screening methods and proteases identified thereby | |
WO2008045307A3 (en) | Emissive compositions with internal standard and related techniques | |
WO2009064006A1 (ja) | γ-セクレターゼの新規基質EphA7を利用したスクリーニング方法 | |
WO2006078289A3 (en) | Bio-barcode based detection of target analytes | |
WO2008030979A3 (en) | Methods of screening for gastrointestinal cancer | |
WO2007120265A3 (en) | Coded molecules for detecting target analytes | |
ATE514755T1 (de) | Fluoreszenzfarbstoffe zur verwendung bei der glukoseerfassung | |
EP1952280B8 (en) | System, method&computer program product for concept based searching&analysis | |
TW200726845A (en) | Biomarker molecular of renal illness and detecting method for the same | |
WO2008020823A3 (en) | Cooperative reporter systems, components, and methods for analyte detection | |
WO2006069023A3 (en) | Assay method and apparatus with reduced sample matrix effects | |
WO2008019086A3 (en) | Detection of explosives, toxins and other compositions | |
HK1119244A1 (en) | Detecting and predicting pre-eclampsia | |
WO2002054067A3 (en) | Detection of analytes | |
WO2008140581A3 (en) | Systems and methods for preparing and analyzing samples | |
WO2006132797A3 (en) | Preparation of small liquid samples for automated analysis | |
WO2010061283A3 (en) | Biomarkers for diagnosing and detecting the progression of neurodegenerative disorders, in particular of amyotrophic lateral sclerosis | |
WO2011144914A3 (en) | Diagnostic methods | |
WO2006085121A3 (en) | Vgp peptide fragments as biomarkers for schizophrenic and bipolar disorders | |
WO2009019370A3 (fr) | Procede de dosage de l'apolipoproteine aii pour le diagnostic in vitro du cancer colorectal | |
WO2006092729A3 (en) | Novel biomarkers for diagnosis and/or prognosis or prognosis of neoplasias in animals | |
WO2009017234A1 (ja) | γ-セクレターゼの新規基質c-Retを利用したスクリーニング方法 | |
WO2006112713A3 (en) | High throughput screening method for assessing heterogeneity of microorganisms |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 08791346 Country of ref document: EP Kind code of ref document: A1 |
|
ENP | Entry into the national phase |
Ref document number: 2009523688 Country of ref document: JP Kind code of ref document: A |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2008791346 Country of ref document: EP |